About Xenogen
Xenogen is a company based in Alameda (United States) founded in 1994 was acquired by Taconic in December 2009. Xenogen has raised $47 million across 2 funding rounds from investors including Chevron, Abingworth and Taconic Biosciences. Xenogen operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Alameda, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Xenogen Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Xenogen
Xenogen has successfully raised a total of $47M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $22 million completed in July 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xenogen
Xenogen has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Chevron, Abingworth and Taconic Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in US
|
Locked | Locked | Locked | |
|
A biotechnology venture capital firm investing in innovative science.
|
Locked | Locked | Locked | |
|
Provider of wealth management services
|
Locked | Locked | Locked |
Investor details for Xenogen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xenogen
Investment portfolio details for Xenogen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xenogen
Detailed financials for Xenogen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xenogen Comparisons
Peer comparison for Xenogen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xenogen
Xenogen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of Xenogen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xenogen
Complete news archive for Xenogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xenogen
Xenogen was founded in 1994 and raised its 1st funding round 7 years after it was founded.
Xenogen is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Xenogen is a funded company, having raised a total of $47M across 2 funding rounds to date.
Xenogen was founded in 1994 in Alameda, United States, within the biotechnology sector. In vivo target and compound evaluation services are offered, alongside the design, production, and phenotyping of genetically modified animal models, particularly rodents. These operations support drug development processes for pharmaceutical and research entities across the United States.
Xenogen's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Xenogen has 6 investors. Key investors include Chevron, Abingworth, Taconic Biosciences, Lombard Odier, and Caliper Life Sciences.